- Report
- August 2025
- 193 Pages
Global
From €3168EUR$3,545USD£2,793GBP
€3520EUR$3,939USD£3,103GBP
- Report
- August 2025
- 192 Pages
Global
From €3168EUR$3,545USD£2,793GBP
€3520EUR$3,939USD£3,103GBP
- Report
- August 2025
- 187 Pages
Global
From €3168EUR$3,545USD£2,793GBP
€3520EUR$3,939USD£3,103GBP
- Report
- March 2025
- 200 Pages
Global
From €2225EUR$2,490USD£1,961GBP
- Report
- March 2025
- 200 Pages
Global
From €2225EUR$2,490USD£1,961GBP
- Report
- August 2025
- 200 Pages
Global
From €2225EUR$2,490USD£1,961GBP
- Report
- May 2025
- 200 Pages
Global
From €2225EUR$2,490USD£1,961GBP
- Report
- May 2025
- 200 Pages
Global
From €2225EUR$2,490USD£1,961GBP
- Report
- April 2025
- 175 Pages
Global
From €4012EUR$4,490USD£3,537GBP
- Report
- January 2025
- 175 Pages
Global
From €4012EUR$4,490USD£3,537GBP
- Report
- January 2025
- 175 Pages
Global
From €4012EUR$4,490USD£3,537GBP
- Report
- November 2025
- 279 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 288 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 177 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 464 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 476 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 368 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 486 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 375 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 262 Pages
Global
From €5227EUR$5,850USD£4,608GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more